Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 3
1976 9
1977 17
1978 30
1979 37
1980 43
1981 42
1982 51
1983 41
1984 45
1985 70
1986 53
1987 62
1988 99
1989 171
1990 211
1991 295
1992 320
1993 364
1994 367
1995 380
1996 420
1997 411
1998 411
1999 441
2000 376
2001 405
2002 447
2003 406
2004 490
2005 490
2006 550
2007 565
2008 558
2009 515
2010 570
2011 580
2012 612
2013 607
2014 606
2015 605
2016 610
2017 562
2018 544
2019 592
2020 613
2021 625
2022 560
2023 531
2024 509
2025 108

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,357 results

Results by year

Filters applied: . Clear all
Page 1
Fluoxetine.
Gram L. Gram L. N Engl J Med. 1994 Nov 17;331(20):1354-61. doi: 10.1056/NEJM199411173312008. N Engl J Med. 1994. PMID: 7935707 Review.
Fluoxetine is almost as effective as tricyclic antidepressant drugs, but the available studies do not allow accurate comparisons. ...Fluoxetine may be most appropriate for patients with moderate depression who can be treated as outpatients. ...
Fluoxetine is almost as effective as tricyclic antidepressant drugs, but the available studies do not allow accurate comparisons. ...
Fluoxetine: a case history of its discovery and preclinical development.
Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA, Berrocoso E. Perez-Caballero L, et al. Expert Opin Drug Discov. 2014 May;9(5):567-78. doi: 10.1517/17460441.2014.907790. Epub 2014 Apr 16. Expert Opin Drug Discov. 2014. PMID: 24738878 Review.
Furthermore, the authors review the effect of fluoxetine on neuroplasticity and adult neurogenesis. In addition, the article summarises the preclinical behavioural data available on fluoxetine's effects on depressive-like behaviour, anxiety and cognition as w …
Furthermore, the authors review the effect of fluoxetine on neuroplasticity and adult neurogenesis. In addition, the article summaris …
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P, Heel RC, Lewis SP. Benfield P, et al. Drugs. 1986 Dec;32(6):481-508. doi: 10.2165/00003495-198632060-00002. Drugs. 1986. PMID: 2878798 Review.
Preliminary data have shown that patients with bipolar depression gained similar therapeutic benefit from fluoxetine or imipramine. Other preliminary trials have indicated that fluoxetine may be useful in obsessive-compulsive disorders. ...Nausea, nervousness and in …
Preliminary data have shown that patients with bipolar depression gained similar therapeutic benefit from fluoxetine or imipramine. O …
[Fluoxetine].
Gleiter CH, Volz HP. Gleiter CH, et al. Dtsch Med Wochenschr. 1997 Apr 11;122(15):481-2. doi: 10.1055/s-0029-1237401. Dtsch Med Wochenschr. 1997. PMID: 9147940 German. No abstract available.
Are all antidepressants really the same? The case of fluoxetine: a systematic review.
Cipriani A, Barbui C, Brambilla P, Furukawa TA, Hotopf M, Geddes JR. Cipriani A, et al. J Clin Psychiatry. 2006 Jun;67(6):850-64. doi: 10.4088/jcp.v67n0601. J Clin Psychiatry. 2006. PMID: 16848644 Review.
MEDLINE (1966-2004) and EMBASE (1974-2004) were searched using fluoxetine and randomized controlled trial or random allocation or double-blind method. No language restrictions were applied. ...In terms of efficacy, we found a statistically significant difference favoring s …
MEDLINE (1966-2004) and EMBASE (1974-2004) were searched using fluoxetine and randomized controlled trial or random allocation or dou …
Fluoxetine: a five-year review.
Stokes PE. Stokes PE. Clin Ther. 1993 Mar-Apr;15(2):216-43; discussion 215. Clin Ther. 1993. PMID: 8519034 Review.
Large-scale trials showed fluoxetine to be as effective as existing agents, but because of its selectivity, the side effects of fluoxetine treatment are generally mild and transient and rarely cause premature discontinuation of therapy. In clinical trials approximat …
Large-scale trials showed fluoxetine to be as effective as existing agents, but because of its selectivity, the side effects of fl
The human pharmacology of fluoxetine.
Lucas RA. Lucas RA. Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 4:S49-54. Int J Obes Relat Metab Disord. 1992. PMID: 1338386 Review.
Fluoxetine is a potent and specific inhibitor of 5-HT uptake even after prolonged dosing. Both fluoxetine and norfluoxetine, an active metabolite, have a long plasma half life. The drug is extensively metabolized and undergoes renal elimination. ...
Fluoxetine is a potent and specific inhibitor of 5-HT uptake even after prolonged dosing. Both fluoxetine and norfluoxetine, a
Fluoxetine and bulimia.
Wilcox JA. Wilcox JA. J Psychoactive Drugs. 1990 Jan-Mar;22(1):81-2. doi: 10.1080/02791072.1990.10472200. J Psychoactive Drugs. 1990. PMID: 2324866 No abstract available.
Fluoxetine: a suitable long-term treatment.
Calil HM. Calil HM. J Clin Psychiatry. 2001;62 Suppl 22:24-9. J Clin Psychiatry. 2001. PMID: 11599644 Review.
A review of fluoxetine's safety profile, especially during long-term treatment, is presented. Key safety advantages for fluoxetine include lower adverse events and dropout rates compared with tricyclic antidepressants and other selective serotonin reuptake in …
A review of fluoxetine's safety profile, especially during long-term treatment, is presented. Key safety advantages for flu
16,357 results
You have reached the last available page of results. Please see the User Guide for more information.